Skip to content

Resistance Training as Treatment of Achilles Tendinopathy

Heavy Slow Resistance Versus Eccentric Training in the Treatment of Achilles Tendinopathy. A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00952042
Enrollment
47
Registered
2009-08-04
Start date
2009-07-31
Completion date
2012-10-31
Last updated
2014-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendinopathy

Keywords

Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training

Brief summary

The use of eccentric resistance training as management of Achilles tendinopathy is widespread. The investigators have recently demonstrated that heavy slow resistance training was superior in the management of patellar tendinopathy. Hypothesis: heavy slow resistance training is more effective than eccentric resistance training in the clinical management of Achilles tendinopathy.

Interventions

Heel-raises. 12-6RM. each contraction performed slowly. three times weekly for 12 weeks

Eccentric heel-raises. 3 x 15 reps performed twice daily for 12 wks.

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Unilateral Achilles tendon pain, * Symptoms for at least three months, * Ultrasonographical tendon abnormalities, AND * Able to comply with both intervention arms.

Exclusion criteria

* Bilateral symptoms, * Previous surgery below knee, * Corticosteroid injections below the knee during past year, * Hypercholesterol, * Diabetes, OR * Arthritis.

Design outcomes

Primary

MeasureTime frame
VISA-A score0,12 wks + 1yr follow-up

Secondary

MeasureTime frame
Tendon thickness0,12 wks + 1yr follow-up

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026